Recent advances in microfluidic biosensing technologies for the detection of infectious pathogens

Key Points

• Improved biosensing technologies enable rapid pathogen detection, enhancing timely diagnostics.
• Significantly, recent advancements have led to detection sensitivities reaching as low as 1 CFU/mL in targeted assays.
• Assessment using microfluidic platforms highlights the versatility of immunoassays for various infectious agents.
• This advances diagnostic technologies, emphasizing the need for further validation in clinical settings.